`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`_______________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`_______________
`
`
`
`DR. REDDY’S LABORATORIES, LTD. AND DR. REDDY’S
`LABORATORIES, INC.,
`Petitioners
`
`v.
`
`MONOSOL RX, LLC,
`Patent Owner
`_______________
`
`Case: IPR2016-01111
`
`Patent 8,603,514
`_______________
`
`PATENT OWNER MONOSOL RX, LLC’S UPDATED EXHIBIT LIST
`
`
`
`
`
`EXHIBIT
`
`*2001
`*2002
`
`*2003
`
`*2004
`
`*2005
`
`*2006
`*2007
`*2008
`
`*2009
`
`*2010
`
`*2011
`
`*2012
`
`*2013
`
`2014
`
`IPR2016-01111
`
`PATENT OWNER’S EXHIBIT LIST
`
`
`DESCRIPTION
`
`Transcript of Conference Call of August 1, 2015
`Redline comparison of Teva petition in IPR2016-00281
`and Dr.Reddy’s petition in IPR2016-01111
`Redline comparison of Dr. Panyam declaration in Teva
`IPR2016-00281 and Dr. Celik declaration in Dr.
`Reddy’s IPR2016-01111
`“Dr. Reddy’s to acquire product portfolio from TEVA
`for US Market,” Press Release, June 11, 2016
`Email from Dr. Reddy’s counsel summarizing meet and
`confer teleconference conducted July 6, 2016
`Teva/Allergan Divestiture Products Table
`FTC Complaint with list of products
`“Teva Pharm finalizing asset sales to clear Allergan
`deal: source,” Reuters, May 5, 2016
`June 3, 2016 Trial Opinion, Reckitt v. Watson, 1:13-cv-
`1674 (D. Del.) (Richard G. Andrews, J.)
`J. O. Morales and J. T. McConville, Manufacture and
`Characterization of Mucoadhesive Buccal Films,
`European Journal of Pharmaceutics and v
`Biopharmaceutics 77, pp. 187-99 (2011)
`A. F. Borges et al., Oral Films: Current Status and
`Future Perspectives II – Intellectual Property,
`Technologies and Market Needs, Journal of Controlled
`Release 206, pp. 108-21 (2015).
`V.A. Perumal et al., Investigating a New Approach to
`Film Casting for Enhanced Drug Content Uniformity in
`Polymeric Films, Drug Dev. & Indust. Pharm. 34, pp.
`1036-47 (2008).
`H. Kathpalia and A. Gupte, An Introduction to Fast
`Dissolving Oral Thin Film Drug Delivery Systems: A
`Review, Drug Delivery & Formulation 10, pp. 667-84
`(2013).
`Email correspondence between counsel for Patent
`Owner and Petitioner, September 8-9, 2016
`
`
`
`
`*Patent Owner’s exhibits 2001-2013 were previously filed and are listed here again
`
`IPR2016-01111
`
`pursuant to 37 C.F.R. § 42.63.
`
`
`
`Date: September 14, 2016
`
`Steptoe & Johnson LLP
`1330 Connecticut Avenue, N.W.
`Washington, DC 20036-1795
`Telephone: (202) 429-3000
`Facsimile: (202) 429-3902
`
`Respectfully submitted,
`
`/Harold H. Fox/
`
`
`
`
`
`Harold H. Fox
`Reg. No. 41,498
`Counsel for MonoSol Rx, LLC
`
`
`
`IPR2016-01111
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. § 42.6, I hereby certify that on this 14th day of
`
`
`
`September 2016, the foregoing PATENT OWNER MONOSOL RX, LLC’S
`
`UPDATED EXHIBIT LIST were served by filing this document through the
`
`Patent Trial Appeal Board End To End system as well as by delivering a copy via
`
`electronic mail, by agreement of the parties, on the following counsel of record for
`
`Jeffrey B. Arnold
`jarnold@cantorcolburn.com
`Peter R. Hagerty
`phagerty@cantorcolburn.com
`Leslie-Ann Maxwell, Ph.D.
`amaxwell@cantorcolburn.com
`Andrew C. Ryan
`ryan@cantorcolburn.com
`Cantor Colburn LLP
`
`
`
`Petitioner.
`
`
`
`
`
`Date: September 14, 2016
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`/Harold H. Fox/
`Harold H. Fox
`Reg. No. 41,498
`
`
`
`
`
`
`
`
`
`
`
`